Skip to main content
OpenTrials

Clinical trial condition

Lung Diseases, Interstitial

Explore clinical trials studying Lung Diseases, Interstitial. Study availability and eligibility vary by location and protocol.

725 public trials 133 recruiting studies
Refine in advanced search Browse all conditions

Lung Diseases, Interstitial trial results

Active, Not Recruiting

A Phase 2 Study of CAL101 in Patients With Idiopathic Pulmonary Fibrosis

NCT06736990

Conditions
Idiopathic Pulmonary Fibrosis, Lung Diseases, Lung Diseases, Interstitial, +2 more
Locations
  • Keck School of Medicine at USC Los Angeles, California, United States
  • National Jewish Health Denver, Colorado, United States
  • Y & L Advance Health Care, Inc. d/b/a Elite Clinical Research Miami, Florida, United States
  • University of Kansas Medical Center Kansas City, Kansas, United States
View all 54 locations
View Trial Details
Active, Not Recruiting

LCH-IV, International Collaborative Treatment Protocol for Children and Adolescents With Langerhans Cell Histiocytosis

NCT02205762

Conditions
Hemic and Lymphatic Diseases, Histiocytosis, Histiocytosis, Langerhans-Cell, +5 more
Locations
  • Children's of Alabama Birmingham, Alabama, United States
  • Phoenix Children's Hospital Phoenix, Arizona, United States
  • Arkansas Children's Hospital Little Rock, Arkansas, United States
  • Children's Hospital of Los Angeles Los Angeles, California, United States
View all 42 locations
View Trial Details
Active, Not Recruiting

A Prognostic Transcriptomic Signature for Chronic Hypersensitivity Pneumonitis

NCT04844359

Conditions
Alveolitis, Extrinsic Allergic, Hypersensitivity, Hypersensitivity Pneumonitis, +6 more
Locations
  • University of Arizona Tucson, Arizona, United States
  • University of California Davis Sacramento, California, United States
  • National Jewish Health Denver, Colorado, United States
  • University of Chicago Chicago, Illinois, United States
View Trial Details
Active, Not Recruiting

MAXPIRe: Study to Evaluate Axatilimab in Participants With Idiopathic Pulmonary Fibrosis (IPF)

NCT06132256

Conditions
Idiopathic Pulmonary Fibrosis, Lung Diseases, Lung Diseases, Interstitial, +2 more
Locations
  • Royal Prince Alfred Hospital Camperdown, New South Wales, Australia
  • Sunshine Coast University Hospital Birtinya, Queensland, Australia
  • Wallace Street Specialist Centre Brisbane, Queensland, Australia
  • Mater Misericordiae Ltd South Brisbane, Queensland, Australia
View all 78 locations
View Trial Details
Active, Not Recruiting

A Study to Evaluate the Efficacy, Safety, and Tolerability of BMS-986278 in Participants With Idiopathic Pulmonary Fibrosis

NCT06003426

Conditions
Fibrosis, Idiopathic Pulmonary Fibrosis, Lung Diseases, +5 more
Locations
  • Local Institution - 0189 Birmingham, Alabama, United States
  • Local Institution - 0361 Phoenix, Arizona, United States
  • Local Institution - 0396 La Jolla, California, United States
  • Local Institution - 0193 Los Angeles, California, United States
View all 390 locations
View Trial Details
Active, Not Recruiting

Sirolimus in Combination With Metronomic Chemotherapy in Children With Recurrent and/or Refractory Solid and CNS Tumors

NCT02574728

Conditions
Brain Diseases, Brain Neoplasms, Cancer, +38 more
Locations
  • Phoenix Children's Hospital Phoenix, Arizona, United States
  • Nemours/Alfred I. duPont Hospital for Children Wilmington, Delaware, United States
  • Children's Healthcare of Atlanta-Egleston Atlanta, Georgia, United States
  • Children's Healthcare of Atlanta, Scottish Rite Atlanta, Georgia, United States
View Trial Details

Related conditions